MedPath

Comparing two drugs in two different routes for reducing the cardiovascular changes associated with laryngoscopy and intubation.

Phase 4
Conditions
Health Condition 1: K352- Acute appendicitis with generalized peritonitisHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2021/04/032996
Lead Sponsor
KLE Dr Prabhakar Kore Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ASA 1 and 2

2.Patients undergoing elective surgeries under general anaesthesia with endotracheal intubation.

3. Provides consent

Exclusion Criteria

1. Patient refusal or who are unable to give consent.

2. ASA physical status 3 or more.

3. Patients allergic to drug under study.

4. Patients undergoing emergency surgery.

5. Patients with nasal pathology.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparision of intranasal dexmedetomidine with intravenous preservative free lignocaine with respect to hemodynamic variables like Mean arterial pressure, Systolic blood pressure, Diastolic blood pressure and Heart rate.Timepoint: Pre induction for Dexmedetomidine <br/ ><br>0mins 10 mins 20 mins 30 mins <br/ ><br>Pre induction for Lignocaine <br/ ><br>0min 3mins <br/ ><br>Post induction for both dexmedetomidine and lignocaine <br/ ><br>atL-I 1min 2min 3min 4min 5min 7min 10min <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To determine the incidence of side effects and complications.Timepoint: 0 to 10 mins
© Copyright 2025. All Rights Reserved by MedPath